Alimera Sciences Kiemelkedően
Mi az Alimera Sciences Kiemelkedően?
A Kiemelkedően az Alimera Sciences Inc. - 54.384M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a Alimera Sciences -hoz képest
Mit csinál Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
kiemelkedően -hoz hasonló cégek Alimera Sciences
- Lindblad Expeditions Inc nak Kiemelkedően 54.319M van
- BelaraRox Ltd nak Kiemelkedően 54.330M van
- NP3 Fastigheter AB (publ) nak Kiemelkedően 54.339M van
- Blackline Safety nak Kiemelkedően 54.349M van
- IPL Plastics nak Kiemelkedően 54.382M van
- Sol Cuisine Ltd nak Kiemelkedően 54.382M van
- Alimera Sciences nak Kiemelkedően 54.384M van
- 827013 nak Kiemelkedően 54.385M van
- Veritex Inc nak Kiemelkedően 54.386M van
- Smith & Wesson Brands nak Kiemelkedően 54.389M van
- Kudelski SA nak Kiemelkedően 54.390M van
- Galera Therapeutics Inc nak Kiemelkedően 54.392M van
- PIMCO Corporate & Income Strategy Fund nak Kiemelkedően 54.406M van